Lymphangioma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 15: | Line 15: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Vascular medicine]] | |||
Revision as of 02:22, 27 November 2017
|
Lymphangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangioma risk factors On the Web |
|
American Roentgen Ray Society Images of Lymphangioma risk factors |
|
Risk calculators and risk factors for Lymphangioma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as Turner syndrome, Down syndrome, and Noonan syndrome.[1][2][3][4]
Risk Factors
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as Turner syndrome, Down syndrome, and Noonan syndrome.
References
- ↑ Lymphangioma. Wikipedia (2016) https://en.wikipedia.org/wiki/Lymphangioma Accessed on March 3, 2015
- ↑ Lymphangioma. PathologyOutlines (2016) http://www.pathologyoutlines.com/topic/softtissuelymphangiomacystic.html Accessed on March 5, 2016
- ↑ Lymphangioma. Libre Pathology (2016) http://librepathology.org/wiki/Vascular_tumours#Lymphangioma Accessed on March 5, 2016
- ↑ Lymphangioma. Radiopeadia (2016) http://radiopaedia.org/articles/lymphangioma Accessed on March 5, 2016